Elevated Plasma PCSK9 Is Equally Detrimental for Non-Familial Hypercholesterolemic (Non-FH) and Heterozygous FH Patients, Irrespective of Their LDL Receptor Defects

Study Questions:

What is the risk of elevated PCSK9 levels in subjects with reduced low-density lipoprotein receptor (LDLR) levels?